The Human and Economic Burden of Diabetes and Its Comorbidities
Sep 18, 2021
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Sameen Khan, Pharm.D. Candidate, USF College of Pharmacy
Every comorbidity related to diabetes causes life expectancy to plummet and medical costs to soar.
Projections indicate that by the year 2045, there will be 693 million diabetes cases throughout the world, a steady increase from the 451 million cases in 2017. Along with a decrease in life expectancy, this disease growth will cause healthcare costs to rise much higher than the estimated $600-1200 billion (in US dollars) annual global cost of diabetes in 2014. To be prepared for future challenges, patients and healthcare workers need to be aware of the higher mortality rates and increased costs of treatment associated with diabetes, which rise even more when combined with comorbidities such as cardiovascular disease (CVD) and chronic kidney disease (CKD). A May 2020 Hong Kong-based study published in the journal Diabetes Care quantified the effects of diabetes and related comorbidities with healthcare costs and life expectancy....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.